Denali Advisors’s Amgen AMGN Stock Holding History

Denali Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,300	Closed	-$1.1M	–	267
2017 Q4	$1.1M	Buy	+6,300	New	+$1.11M	0.17%	89

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Denali Advisors's AMGN Position: Q1 2018 in Review

Denali Advisors sold out of Amgen (AMGN) in Q1 2018, closing a stake of 6,300 shares — an estimated $1.1M sold.

Denali Advisors first reported a position in AMGN in Q4 2017 and held it in 1 quarter. The position peaked at $1.1M in Q4 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

Denali Advisors reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
Denali Advisors sold 6,300 Amgen shares in Q1 2018, an estimated $1.1M.
Denali Advisors first reported a position in Amgen in Q4 2017 and held it in 1 quarter.
Denali Advisors's Amgen position peaked at $1.1M in Q4 2017.
1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Denali Advisors's 13F filing for Q1 2018, filed 23 Apr 2018.